Hypothesis: ruthenium-based photo activated chemotherapy compounds are activated by photo substitution, which is independent from the presence of dioxygen. Hence phytotoxicity is kept in hypoxic cancer cells.
Method: we have developed a setup to shine light on living cancer cells in a controlled atmosphere, with the O2 concentration comprised between 1 and 21%. We use this setup to study the influence of hypoxia on the dose-response curve of a series of ruthenium-based photo activated compounds.
Results: with different ruthenium compounds the photo index remains indeed independent on the concentration of O2. However, the IC50 in the dark and after light irradiation are often higher under hypoxia, compared to normoxia.
Conclusion: photo activated chemotherapy compounds are indeed promising for killing hypoxic cancer cells, but synergistic effects may be needed to obtain high photo indexes under hypoxia.
Conference Committee Involvement (1)
17th International Photodynamic Association World Congress
28 June 2019 | Cambridge, Massachusetts, United States
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.